Belgium· BE-AMP-SAM366807-00

Elonva 150 µg

A corifollitropin alfa product containing corifollitropin alfa, registered in Belgium by Organon. The same ATC class is registered in 10 of our 19 countries.

ATC G03GA09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedElonva 150 µgATCG03GA09REGISTER NO.BE-AMP-SAM366807-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Corifollitropin alfa is registered in 10 of 19 countries.

Countries holding a registration under ATC G03GA09 (corifollitropin alfa), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Corifollitropin alfa · ATC G03GA09

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Corifollitropin Alfa
Manufacturer
Organon
Country
Belgium (BE)
ATC code
G03GA09
ATC class
Corifollitropin alfa
Defined daily dose
0.15 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2709194

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Corifollitropin alfa in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All corifollitropin alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Elonva
  • Liechtenstein · Elonva
  • Norway · Elonva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8ecc79d7-df8c-44e8-a8c0-4a8143b1683b
GET /v1/drugs/8ecc79d7-df8c-44e8-a8c0-4a8143b1683b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Elonva 150 µg",
  "name_fr": "Elonva 150 µg",
  "name_nl": "Elonva 150 µg",
  "amp_code": "SAM366807-00",
  "strengths": [
    "150.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Corifollitropin Alfa",
    "Sodium Hydroxide",
    "Sucrose",
    "Polysorbate 20"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Corifollitropin Alfa",
  "authorisation_numbers": [
    "EU/1/09/609/002"
  ]
}

See everything about corifollitropin alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.